🇺🇸 Immunoglobulins in United States

1,668 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 451 reports (27.04%)
  2. Off Label Use — 401 reports (24.04%)
  3. Condition Aggravated — 132 reports (7.91%)
  4. Product Use In Unapproved Indication — 116 reports (6.95%)
  5. Diarrhoea — 114 reports (6.83%)
  6. Pyrexia — 105 reports (6.29%)
  7. Pneumonia — 92 reports (5.52%)
  8. Septic Shock — 88 reports (5.28%)
  9. Thrombocytopenia — 86 reports (5.16%)
  10. Vomiting — 83 reports (4.98%)

Source database →

Other Immunology approved in United States

Frequently asked questions

Is Immunoglobulins approved in United States?

Immunoglobulins does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Immunoglobulins in United States?

Rigshospitalet, Denmark is the originator. The local marketing authorisation holder may differ — check the official source linked above.